1. FGF-2-induced negative inotropism and cardioprotection are inhibited by chelerythrine: involvement of sarcolemmal calcium-independent protein kinase C.
- Author
-
Padua RR, Merle PL, Doble BW, Yu CH, Zahradka P, Pierce GN, Panagia V, and Kardami E
- Subjects
- Alkaloids, Animals, Benzophenanthridines, Blotting, Western, Calcium pharmacology, Calcium-Calmodulin-Dependent Protein Kinases drug effects, Cells, Cultured, Cytosol drug effects, Densitometry, Enzyme Inhibitors pharmacology, Fibroblast Growth Factor 2 pharmacology, Fibroblast Growth Factor 2 physiology, Fluorescent Antibody Technique, Male, Membranes drug effects, Perfusion, Protein Kinase C antagonists & inhibitors, Rats, Rats, Sprague-Dawley, Reperfusion Injury drug therapy, Reperfusion Injury prevention & control, Time Factors, Ventricular Function, Left drug effects, Fibroblast Growth Factor 2 antagonists & inhibitors, Myocardial Contraction drug effects, Phenanthridines pharmacology, Protein Kinase C physiology, Sarcolemma enzymology
- Abstract
Fibroblast growth factor-2 (FGF-2), administered to the isolated rat heart by perfusion and under constant pressure, is protective against ischemia-reperfusion (I-R). Here we have investigated whether FGF-2 cardioprotection: (a) is dependent on flow modulation; (b) is linked to effects on contractility; (c) is mediated by protein kinase C (PKC); and (d) is linked to PKC and/or mitogen activated protein kinase (MAPK) associated with the sarcolemma. The isolated rat heart was used as a model. Under conditions of constant flow FGF-2 induced significant improvement in recovery of contractile function during I-R. Under constant perfusion pressure, FGF-2 induced a negative inotropic effect (15% decrease in developed pressure). Chelerythrine, a specific PKC inhibitor, prevented both the FGF-2-induced negative inotropic effect before ischemia, and cardioprotection during I-R. FGF-2 induced a chelerythrine-preventable, five-fold increase in sarcolemmal calcium-independent PKC activity. It also increased the association of PKC subtypes -epsilon and -delta with sarcolemmal membranes, detected by Western blotting, as well as, for PKC delta, by immunolocalization. FGF-2 increased the association of PKC epsilon with the membrane fraction of adult cardiomyocyte in culture, confirming that it can affect PKC signaling in cardiomyocytes directly and in a manner similar to its effects in situ. Finally, FGF-2 induced increased active MAPK at sarcolemmal as well as cytosolic sites. Active sarcolemmal MAPK remained elevated when the FGF-2-induced protection was prevented by chelerythrine. In conclusion, we have provided evidence that cardioprotection by FGF-2 is independent of flow modulation. PKC activation mediates both the FGF-2-induced negative inotropic effect before ischemia and the cardioprotective effect assessed during reperfusion, suggesting a cause and effect relationship. Furthermore, FGF-2 cardioprotection is linked to targeting of sarcolemmal sites by calcium-independent PKC.
- Published
- 1998
- Full Text
- View/download PDF